trying...
247007072014111220151119
0891-98872732014SepJournal of geriatric psychiatry and neurologyJ Geriatr Psychiatry NeurolAbridged scale for the screening anosognosia in patients with dementia.220226220-610.1177/0891988714527515The objective of this cross-sectional study was to validate an abridged version of the Anosognosia Questionnaire--Dementia (AQ-D) for screening anosognosia in daily practice. The authors reduce the AQ-D from 30 items to 9, with a large sample (n = 352) of patients with Alzheimer disease (AD). The Cronbach α was .793 and an area under the receiver-operating characteristic curve was 0.946. The κ index between new abridged AQ-D (AAQ) and original AQ-D was .800. The AAQ presents good validity and reliability indicators and kept concordance with the original scale. It is quick and easy to administer and it can simplify the clinical screening of anosognosia in patients with AD.© The Author(s) 2014.Turró-GarrigaOriolOResearch Unit, Institut d'Assistència Sanitària de Girona, Salt, Catalonia, Spain oriol.turro@ias.cat.Garre-OlmoJosepJResearch Unit, Institut d'Assistència Sanitària de Girona, Salt, Catalonia, Spain Department of Psychology, University of Girona, Girona, Catalonia, Spain.López-PousaSecundinoSResearch Unit, Institut d'Assistència Sanitària de Girona, Salt, Catalonia, Spain Dementia Unit, Hospital Santa Caterina, Institut d'Assistència Sanitària de Girona, Salt, Catalonia, Spain Department of Medicine, University of Girona, Girona, Catalonia, Spain.Vilalta-FranchJoanJDementia Unit, Hospital Santa Caterina, Institut d'Assistència Sanitària de Girona, Salt, Catalonia, Spain Department of Medicine, University of Girona, Girona, Catalonia, Spain.Reñé-RamírezRamónRDementia Unit, Hospital Universitari de Bellvitge, Hospitalet de Llobregat, Catalonia, Spain.Conde-SalaJosep LluísJLDepartment of Developmental Psychology, University of Barcelona, Barcelona, Catalonia, Spain.engJournal ArticleResearch Support, Non-U.S. Gov't20140402
United StatesJ Geriatr Psychiatry Neurol88056450891-9887IMAgedAged, 80 and overAgnosiadiagnosisCross-Sectional StudiesDementiacomplicationsFemaleHumansMaleMass ScreeningmethodsROC CurveReproducibility of ResultsSurveys and QuestionnairesAlzheimer diseaseagnosiaawarenesscognitive disordersdementianeuropsychological tests
20144560201445602014111360ppublish2470070710.1177/08919887145275150891988714527515
trying2...
trying...
1775501MCID_676f085bc771a53fc80e5394 39689339 39563125 39514339 39462748 39459428 screening "diagnosis"[Subheading] OR "diagnosis"[All Fields] OR "screening"[All Fields] OR "mass screening"[MeSH Terms] OR ("mass"[All Fields] AND "screening"[All Fields]) OR "mass screening"[All Fields] OR "early detection of cancer"[MeSH Terms] OR ("early"[All Fields] AND "detection"[All Fields] AND "cancer"[All Fields]) OR "early detection of cancer"[All Fields] OR "screen"[All Fields] OR "screenings"[All Fields] OR "screened"[All Fields] OR "screens"[All Fields] anosognosia "agnosia"[MeSH Terms] OR "agnosia"[All Fields] OR "anosognosia"[All Fields] ("diagnosis"[MeSH Subheading] OR "diagnosis"[All Fields] OR "screening"[All Fields] OR "mass screening"[MeSH Terms] OR ("mass"[All Fields] AND "screening"[All Fields]) OR "mass screening"[All Fields] OR "early detection of cancer"[MeSH Terms] OR ("early"[All Fields] AND "detection"[All Fields] AND "cancer"[All Fields]) OR "early detection of cancer"[All Fields] OR "screen"[All Fields] OR "screenings"[All Fields] OR "screened"[All Fields] OR "screens"[All Fields]) AND ("agnosia"[MeSH Terms] OR "agnosia"[All Fields] OR "anosognosia"[All Fields]) trying2...
trying...
trying2...
Abridged scale for the screening anosognosia in patients with dementia. | LitMetric

The objective of this cross-sectional study was to validate an abridged version of the Anosognosia Questionnaire--Dementia (AQ-D) for screening anosognosia in daily practice. The authors reduce the AQ-D from 30 items to 9, with a large sample (n = 352) of patients with Alzheimer disease (AD). The Cronbach α was .793 and an area under the receiver-operating characteristic curve was 0.946. The κ index between new abridged AQ-D (AAQ) and original AQ-D was .800. The AAQ presents good validity and reliability indicators and kept concordance with the original scale. It is quick and easy to administer and it can simplify the clinical screening of anosognosia in patients with AD.

Download full-text PDF

Source
http://dx.doi.org/10.1177/0891988714527515DOI Listing

Publication Analysis

Top Keywords

screening anosognosia
12
anosognosia patients
8
abridged scale
4
scale screening
4
anosognosia
4
patients dementia
4
dementia objective
4
objective cross-sectional
4
cross-sectional study
4
study validate
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!